[fcb5af]: / literature / by_gene / ZFAT.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 34110462 10.1007/s00277-020-04357-z 2021 Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1<sup>T315I</sup> and BCR-ABL1<sup>T315I-E255K</sup>. ZFAT